Hydrocortisone Patent Expiration

1. Alkindi Sprinkle patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9717740 ETON Treatment of adrenal insufficiency
Nov, 2032

(8 years from now)

US9675559 ETON Treatment of adrenal insufficiency
Jan, 2033

(8 years from now)

US9649280 ETON Composition comprising hydrocortisone
May, 2034

(9 years from now)

Market Authorisation Date: 29 September, 2020

Treatment: Treatment of adrenal insufficiency


More Information on Dosage

ALKINDI SPRINKLE family patents

Family Patents